Login / Signup

Combinatorial Engineering of Escherichia coli for Enhancing 3-Fucosyllactose Production.

Huiyuan HuangWenwen YuXianhao XuYanfeng LiuJianghua LiGuocheng DuXueqin LvLong Liu
Published in: ACS synthetic biology (2024)
3-Fucosyllactose (3-FL) is an important fucosylated human milk oligosaccharide (HMO) with biological functions such as promoting immunity and brain development. Therefore, the construction of microbial cell factories is a promising approach to synthesizing 3-FL from renewable feedstocks. In this study, a combinatorial engineering strategy was used to achieve efficient de novo 3-FL production in Escherichia coli . α-1,3-Fucosyltransferase ( futM 2 ) from Bacteroides gallinaceum was introduced into E. coli and optimized to create a 3-FL-producing chassis strain. Subsequently, the 3-FL titer increased to 5.2 g/L by improving the utilization of the precursor lactose and down-regulating the endogenous competitive pathways. Furthermore, a synthetic membraneless organelle system based on intrinsically disordered proteins was designed to spatially regulate the pathway enzymes, producing 7.3 g/L 3-FL. The supply of the cofactors NADPH and GTP was also enhanced, after which the 3-FL titer of engineered strain E26 was improved to 8.2 g/L in a shake flask and 10.8 g/L in a 3 L fermenter. In this study, we developed a valuable approach for constructing an efficient 3-FL-producing cell factory and provided a versatile workflow for other chassis cells and HMOs.
Keyphrases
  • human milk
  • escherichia coli
  • single cell
  • low birth weight
  • induced apoptosis
  • staphylococcus aureus
  • stem cells
  • cystic fibrosis
  • multidrug resistant
  • reactive oxygen species
  • electronic health record
  • cell cycle arrest